bioMérieux S.A. (BMXXY) Analyst Forecast
Revenue and earnings estimates published by analysts covering bioMérieux S.A. (BMXXY), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For bioMérieux S.A., analysts forecast revenue rising from $3957.25T in 2024 to $4351.49T in 2027; the average estimate for 2027 earnings per share is $0.00; 13 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD millions)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
bioMérieux S.A. (BMXXY) forecast — frequently asked questions
What are analysts forecasting for bioMérieux S.A.'s earnings?
The average analyst estimate for bioMérieux S.A. (BMXXY) earnings per share in 2027 is 0.00, with individual estimates between 0.00 and 0.00.
How much revenue is bioMérieux S.A. expected to make?
Analysts forecast bioMérieux S.A. (BMXXY) revenue of $4351.49T in 2027, based on 13 published estimates.
How many analysts cover BMXXY?
13 analysts contribute estimates for bioMérieux S.A. (BMXXY). Thin coverage makes an average less reliable.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.